Summary
A study on hexachlorophene encephalopathy in mice and baboons is reported. By light microscopy, a severe spongiform lesion of the central nervous system (CNS) was localized in the white matter, without myelin breakdown or cellular reaction. By electron microscopy, the myelin alteration was characterized by wide intralamellar spaces or “splitting” developed in the intraperiod line of compact sheaths. The acute changes described were induced by administration of the drug by the digestive or cutancous routes at various dosage levels in an aqueous solution or in talcum powder. The toxic effects depended on the age of the animals, the survival times and the concentrations of hexachlorophene, i.e., 6%, 3%, and 0.5%. The findings are compared with previous reports on the neurotoxicity of hexachlorophene and other chemicals in humans and experimental animals. Hexachlorophene cannot be recommended for use in young infants because of its neurotoxicity in very low doses as demonstrated in the present report.
Similar content being viewed by others
References
Adornato B, Lampert P (1971) Status spongiosus of nervous tissue. Acta Neuropathol (Berl) 19:271–289
Aleu FP, Katzman R, Terry RD (1963) Fine structure and electrolyte analysis of cerebral edema induced by alkyltin intoxication J Neuropathol Exp Neurol 22:403–414
Blakemore WF, Palmer AC, Noel PRB (1972) Ultrastructural changes in isoniazid-induced brain oedema in the dog. J Neurocytol 1:263
Caldwell RS, Nakaue HS, Buhler DR (1972) Biochemical lesion in rat liver mitochondria induced by hexachlorophene. Biochem Pharmacol 21:2425–2441
Cammer W, Moore CL (1972) The effect of hexachlorophene on the respiration of brain and liver mitochondria. Biochem Biophys Res Commun 46:1887–1894
Cammer W, Rose AL, Norton WT (1975) Biochemical and pathological studies of myelin in hexachlorophene intoxication. Brain Res 98:547–559
Curley A, Hawk RE, Kimbrough RD, Nathenson G, Finberg L (1971) Dermal absorption of hexachlorophane in infants. Lancet II:296–297
FDA Bulletin (1971) Hexachlorophene and newborns (December 1971). DHEW Publication. US Government printing office, Washington DC
Gaines TB, Kimbrough RD (1971) The oral and dermal toxicity of hexachlorophene in rats. Toxicol Appl Pharmacol 19:375–376
Gaines TB, Kimbrough RD, Linder RE (1973) The oral and dermal toxicity of hexachlorophene in rats. Toxicol Appl Pharmacol 25:332–343
Gonatas NK, Zimmerman HM, Levine S (1963) Ultrastructure of inflammation with edema in the rat brain. Am J Pathol 42:455–469
Graham D, Gonatas NK (1975) Triethyltin sulfate-induced splitting of peripheral myelin in rats. Lab Invest 29:627–632
Gruner E (1958) Les lésions du névraxe secondaires à l'ingestion d'éthyl-étain (stalinon). Rev Neurol (Paris) 98:109–116
Gump WS (1969) Toxicological properties of hexachlorophene. J Soc Cosmet Chem 20:173–184
Hall GA, Reid IM (1972) Hexachlorophane toxicity in sheep Lancet II:1251
Hall GA, Reid IM (1974) The effects of hexachlorophane on the nervous system of sheep. J Pathol 114:241–246
Hart ER (1971) Toxicity of pHisoHex on 90-day skin applications to infant rhesus monkeys. Report submitted to Sterling Winthrop Research Institute by Bionetics Research Laboratories December 3, 1971
Hirano A, Zimmerman HM, Levine S (1964) The fine structure of cerebral fluid accumulation. III. Extracellular spread of cryptococcal polysaccharides in the acute stages. Am J Pathol 45: 1–19
Hirano A, Zimmerman HM, Levine S (1968) Intramyelinic and extracellular spaces in triethyltin intoxication. J Neuropathol Exp Neurol 27:571–580
Katzman R, Aleu F, Wilson C (1963) Further observations on triethyltin edema. Arch Neurol 9:178–188
Kennedy GL, Dressler IA, Richter WC, Keplinger ML, Calandra JC (1972) Reversibility of effects caused by HCP in the rat. Toxicol Appl Pharmacol 22:276
Kidd M (1967) Some electron microscopical observations on status spongiosus. Acta Neuropathol (Berl) Suppl III:137
Kimbrough RD (1971) Review of the toxicity of hexachlorophene. Arch Environ Health 23:119–122
Kimbrough RD (1973) Review of recent evidence of toxic effects of hexachlorophene. Pediatrics 51:391–394
Kimbrough RD, Gaines TB (1971) Hexachlorophene effects on the rat brain. Study of high doses by light and electron microscopy. Arch Environ Health 23:114–118
Klatzo I (1967) Neuropathological aspects of brain edema. J Neuropathol Exp Neurol 26:1–4
Kurtz SM, Schardein JL, Fitzgerald JE, Kaunp DH (1969) Toxicologic studies with a halogenated salicylamide. Toxicol Appl Pharmacol 14:652
Lampert P, Schochet S (1968) Electron microscopic observations on experimental spongy degeneration of the cerebellar white matter. J Neuropathol Exp Neurol 27:210–220
Lampert P, O'Brien J, Garrett R (1973a) Hexachlorophene encephalopathy. Acta Neuropathol (Berl) 23:326–333
Lampert P., O'Brien JS, Kaye WH, et al. (1973b) Hexachlorophene encephalopathy. J Neuropathol Exp Neurol 32:178
Larson DL (1968) Studies show hexachlorophene causes burn syndrome. J Am Hosp Assoc 42:63–64
Le Breton R (1962) Etude toxicologique de l'étain et de ses dérivés. Thèse Pharmacie Paris. Imprimerie Mame Tours
Lockhart JD (1972) How toxic is hexachlorophene? Pediatrics 50:229–235
Magee PN, Stoner HB, Barnes JM (1957) The experimental production of oedema in the central nervous system of the rat by triethyltin compounds. J Pathol Bacteriol 73:107–124
Martinez AJ, Boehm R, Hadfield MG (1974) Acute hexachlorophene encephalopathy. Clinico-neuropathological correlation. Acta Neuropathol (Berl) 28:93–103
Mullick FG (1973) Hexachlorophene toxicity. Human experience at the Armed Forces Institute of Pathology. Pediatrics 51:395–399
Nakaue HS, Dost FN, Buhler DR (1973) Studies on toxicity of hexachlorophene in the rat. Toxicol Appl Pharmacol 24:239–249
Nieminen L, Bjondahl K (1973) Effect of hexachlorophene on the rat brain during ontogenesis. Fed Cosmet Toxicol II:635–639
Pleasure D, Towfighi J, Silberberg D, Parris J (1974) The pathogenesis of hexachlorophene neuropathy. In vivo and in vitro studies. Neurology (Minneap) 24:1068–1075
Plueckhahn VD (1973) Hexachlorophene and the control of staphylococcal sepsis in a maternity unit in Geelong, Australia. Pediatrics 51:368–380
Powell HC, Swarner WO, Gluck L, Lampert PW (1973) Hexachlorophene myelinopathy in premature infants. Pediatrics 82:976–981
Powell HC, Lampert PW (1977) Hexachlorophene neurotoxicity. In: Neurotoxicology vol 1. Roizin L, Shiraki H, Grcevic N (eds). Raven Press, New York, pp 381–389
Reid IM, Hall GA (1975) An ultrastructural and biochemical study of hexachlorophene-induced fatty liver in sheep. J Pathol 115: 33–43
Reier PJ, Tabira T, Webster H de F (1978) Hexachlorophene-induced myelin lesions in the amphibian central nervous system. A freeze-fracture study. J Neurol Sci 35:257–274
Rose AL, Wisniewski HM, Cammer W (1974) New observations on hexachlorophene neurotoxicity in rats (Abstract). J Neuropathol Exp Neurol 33:176
Rose AL, Wisniewski HM, Cammer W (1975) Neurotoxicity of hexachlorophene. New pathological and biochemical observations. J Neurol Sci 24:425–435
Santolucito JA (1972) Electroencephalograms and visual evoked potential of the squirrel monkey fed hexachlorophene. Toxicol Appl Pharmacol 22:276
Shunian RM, Leech RW, Alvord EC (1973) Neurotoxicity of hexachlorophene in the human. I. A clinico-pathologic study of 248 children. Pediatrics 54:689–695
Shuman RM, Leech RW, Alvord EC (1975) Neurotoxicity of topically applied hexachlorophene in the young rat. Arch Neurol 32:315–319
Sterling-Winthrop Research Institute (1971) Electron-microscopic observations in the CNS of rhesus monkeys receiving subcutaneous injections of hexachlorophene twice 1 week for 3 months, July 2, 1971
Suzuki K, Kikkawa Y (1969) Status spongiosus of CNS and hepatic changes induced by cuprizone. Am J Pathol 54:307–325
Towfighi J, Gonatas NK (1977) The distribution of peroxidases in the sciatic nerves of normal and hexachlorophene intoxicated developing rats. J Neurocytol 6:39–47
Towfighi J, Gonatas NK, McCree L (1973) Hexachlorophene neuropathy in rats. Lab Invest 29:428–436
Towfighi J, Gonatas NK, McCree L (1974a) Hexachlorophene-induced changes in central and peripheral myelinated axons of developing and adult rats. Lab Invest 31:712–721
Towfighi J, Silberberg D, Parris J (1974b) The pathogenesis of hexachlorophene neuropathy: in vivo and in vitro studies. Neurology (Minneap) 24:1068–1075
Towfighi J, Gonatas NK, McCree L (1975a) Hexachlorophene retinopathy in rats. Lab Invest 32:330–338
Towfighi J, Gonatas NK, McCree L (1976) A study of the development of the perineural barrier in normal and hexachlorophene intoxicated rats. American Association of Neuropathologists, 51th Annual Meeting, May 30–June 1, 1975, J Neuropathol Exp Neurol 35:111
Udall V, Malone JC (1970) Optic nerve atrophy after drug treatment. In: The problems of species differences and statistics in toxicology, vol XI. Excerpta Medica, Amsterdam, pp 244–248
Webster H de F (1980) (Pers. commun.)
Webster H de F, Ulsamer AG, O'Connell MF (1974a) Acute effects of hexachlorophene on the developing nervous system in Xenopus Tadpoles. Morphological and biochemical observations. J Neuropathol Exp Neurol 33:176
Webster H de F, Ulsamer AG, O'Connell MF (1974b) Hexachlorophene-induced myelin lesions in the developing nervous system in Xenopus Tadpoles. Morphological and biochemical observations. J Neuropathol Exp Neurol 33:144–163
Yajima K, Suzuki K (1979) Ultrastructural changes of oligodendroglia and myelin sheaths induced by ethidium bromide. Neuropathol Appl Neurobiol 5:49–62
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tripier, M.F., Bérard, M., Toga, M. et al. Hexachlorophene and the central nervous system. Acta Neuropathol 53, 65–74 (1981). https://doi.org/10.1007/BF00697186
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00697186